HIGHER PREVALENCE OF PATHOGENIC BACTERIA IN ATROPHIC ENDOMETRIA THAN IN NORMAL AND HYPERTROPHIC

To investigate whether endometrial thickness is associated with the presence of pathogenic bacteria, aiming to better understand potential links between anatomical and microbiological findings.

IMPROVED LINING LEADS TO IMPROVED SUBSEQUENT OUTCOMES: ENDOMETRIAL THICKNESS AND PREGNANCY OUTCOMES IN SEQUENTIAL SINGLE EUPLOID FROZEN EMBRYO TRANSFERS

To evaluate the relationship between live birth rates (LBR) and changes in endometrial thickness (EMT) across sequential single euploid frozen embryo transfer (seFET) cycles within the same

SPONTANEOUS PREGNANCY AS A REASON FOR FAILED OOCYTE RETRIEVAL DURING LUTEAL PHASE CONTROLLED OVARIAN STIMULATION CYCLES

To report two cases of spontaneous pregnancy during luteal phase controlled ovarian stimulation (LPCOS) cycles resulting in unexpectedly low oocyte yield at retrieval and to hypothesize a

ASSISTED REPRODUCTIVE TECHNOLOGY (ART) AND TOTAL UTEROTONIC USE

To evaluate whether conception via assisted reproductive technology (ART) is associated with increased postpartum uterotonic medication use in singleton deliveries.

Table of Contents

Fragility index analysis for robustness of evidence in randomized controlled trials leading to the US Food and Drug Administration approval of pharmacological therapies for endometriosis

Endometriosis is a chronic, estrogen-dependent condition affecting approximately 10% of reproductive-aged women and is a major cause of pelvic pain and infertility. The US Food and Drug

ANEUPLOIDY MAY NOT BE TO BLAME: PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) DOES NOT REDUCE BIOCHEMICAL MISCARRIAGE RATES AFTER FROZEN EMBRYO TRANSFER

PGT-A can aid in embryo selection for transfer and has been shown to increase the chances of implantation and pregnancy, reduce the risk of clinical miscarriage, and reduce time to conception

IMPACT OF LABORATORY FACTORS ON THE COLLECTION OF EMBRYONIC CELL-FREE DNA (EC-FDNA) FROM SPENT EMBRYO CULTURE MEDIUM (SECM)

The embryonic cell-free DNA (ec-fDNA) released from embryo culture is used to evaluate the genetic information of the embryo and genetically screen for aneuploidy in a non-invasive manner

EMBRYO PLOIDY PREDICTION USING AN ARTIFICIAL INTELLIGENCE-BASED OOCYTE IMAGE ANALYSIS AND TIME-LAPSE EMBRYO SCORING

To evaluate the predictive performance of an Artificial Intelligence (AI) model designed to estimate embryo ploidy from 2D oocyte images, and to assess whether combining this oocyte-based ploidy

MACHINE LEARNING–DRIVEN INSIGHTS INTO CONTROLLED OVARIAN STIMULATION: TOWARD A TWO-TRACK, LOW-MONITORING STRATEGY

To determine whether mid-cycle laboratory and ultrasound (US) monitoring truly influences medication dosing, monitoring cadence, or trigger timing during controlled ovarian stimulation (COS)—and